BBB Therapeutics is a clinical stage biotechnology company developing novel treatments for devastating brain disorders, such as brain cancer and neuroinflammatory diseases. The Company combines existing drugs with BBB Therapeutics' proprietary G-TechnologyÂŽ for enhanced drug delivery across the blood-brain barrier. BBB Therapeutics currently has two products in clinical trials: its lead product 2B3-101 is in a Phase IIa trial in Europe and the US for the treatment of primary brain tumors as well as brain metastases; the second product 2B3-201 for MS relapses and other neuroinflammatory diseases is completing a Phase I clinical study.
View Top Employees from BBB TherapeuticsWebsite | http://www.bbbtherapeutics.com |
Revenue | $5 million |
Employees | 17 (12 on RocketReach) |
Founded | 2003 |
Address | 19 J.h. Oortweg, Leiden, South Holland, NL |
Phone | +31 71 332 2255 |
Industry | Biotechnology, Business Services General, Drug Delivery, Business Services, Blood-Brain Barrier, Brain Cancer, Neuroinflammation |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541713 Companies, NAICS Code 5417 Companies, NAICS Code 541 Companies |
Looking for a particular BBB Therapeutics employee's phone or email?
The BBB Therapeutics annual revenue was $5 million in 2024.
Michael Sigmon is the Director of Business Development of BBB Therapeutics.
12 people are employed at BBB Therapeutics.
BBB Therapeutics is based in Leiden, South Holland.
The NAICS codes for BBB Therapeutics are [54171, 54, 541713, 5417, 541].
The SIC codes for BBB Therapeutics are [873, 87].